Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Covidien Updates On Voluntary Recall Of BIS Bilateral Sensors - Quick Facts

RELATED NEWS
Trade COV now with 

Covidien Plc (COV: Quote) in its update on voluntary recall of BIS Bilateral Sensors said to date, there have been no reports of patient injury related to the recalled products.

On November 8, 2011, the company initiated a voluntary recall of certain lots of its BIS Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. Covidien noted that this modification could potentially cause a change in the performance of BIS monitoring systems when these sensors are used, resulting in the inaccurate calculation and presentation of processed EEG information for Bispectral Index, or BIS, Density Spectral Array and Asymmetry values.

Click here to receive FREE breaking news email alerts for Covidien Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.